Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cell Adhesion & Migration|August 28, 2010
Movement within and movement beyond: synaptotagmin-mediated vesicle fusion during chemotaxisRichard A Colvin, Andrew D Luster
Plos One|September 22, 2010
CXCL10 can inhibit endothelial cell proliferation independently of CXCR3Gabriele S V Campanella, Richard A Colvin, Andrew D Luster
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2010
iAIDS: HIV-related internet resources for the practicing clinicianDouglas Krakower, Candice K Kwan, David S Yassa, et al.
The Journal of Biological Chemistry|May 20, 2004
Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 functionRichard A Colvin, Gabriele S V Campanella, Jieti Sun, et al.
Molecular and Cellular Biology|July 19, 2006
CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxisRichard A Colvin, Gabriele S V Campanella, Lindsay A Manice, et al.
Journal of Immunological Methods|January 22, 2008
Development of a novel chemokine-mediated in vivo T cell recruitment assayGabriele S V Campanella, Benjamin D Medoff, Lindsay A Manice, et al.
Molecular Therapy. Methods & Clinical Development|December 11, 2023
Drug product attributes predict clinical efficacy in betibeglogene autotemcel gene therapy for β-thalassemiaDustin Whitney, Ilya Shestopalov, Maeva Fincker, et al.
Journal of Drug Assessment|October 30, 2018
A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteersStephen Youngberg, Erin Brandt, Avantika Barve, et al.
The Journal of Biological Chemistry|February 10, 2007
Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signalingBrian D Thompson, Yongzhu Jin, Kevin H Wu, et al.
ACS Infectious Diseases|October 30, 2016
A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical TrialEdward Gane, Catherine Stedman, Kiran Dole, et al.
Pageof 3